AKT1 and laryngeal carcinoma: We previously demonstrated that the PI3K/Akt pathway contributes to chemo‐radioresistance in laryngeal carcinoma.20, 21, 23, 27, 28 However, it remains unclear whether the PI3K/Akt pathway facilitates radioresistance in laryngeal carcinoma cells under hypoxic conditions.